Paperless validation solution optimizing end-to-end validation lifecycle process. SK Life Science case study shows significant cost and time-savings with 50-70% faster validation project cycles.
Veeva Vault Validation Management is a paperless validation solution that optimizes the end-to-end validation lifecycle process for pharmaceutical and biotechnology companies. The platform enables digital validation execution with built-in best practices, centralizing data and improving visibility across all validation activities.
SK Life Science, Inc. (subsidiary of SK Biopharmaceuticals Co. Ltd.) is using Vault Validation Management to streamline and accelerate their validation process (announced January 2024). According to Hina Patel, vice president and global head of quality assurance at SK Life Science: "Veeva Vault Validation Management allows us to further simplify our validation process for significant cost and time-savings in test execution." The company is building off its success with Veeva Vault QualityDocs and Veeva Vault QMS to optimize its validation programs, driving greater compliance and traceability across all systems.
By adopting a validation solution with built-in best practices, companies can execute digital validation while centralizing data and improving visibility. Shifting to a digital approach provides the transparency necessary to identify trends and proactively address potential issues, reducing compliance risks. Veeva estimates the efficiencies gained by automation of validation workflows result in validation project cycles that are 50 to 70% faster.
The platform manages the complete validation lifecycle including IQ/OQ/PQ protocol creation, execution tracking, deviation handling, and validation reporting. Integration with Veeva Vault QMS provides linkage to change control and deviation management when validation issues arise. Integration with Veeva Vault QualityDocs ensures validation documentation remains current with equipment and procedure changes.
Veeva Vault Validation Management is FDA 21 CFR Part 11 compliant with electronic records, electronic signatures, and audit trails. EU Annex 11 compliant and GxP compliant with built-in validation documentation. As part of the Veeva Quality Suite serving 600+ quality customers, Validation Management benefits from unified platform architecture and integration with other quality applications.
Pharmaceutical Edition
Veeva Vault Validation Management is purpose-built exclusively for the life sciences industry. Veeva Systems maintains 100% focus on pharmaceutical, biotechnology, and medical device companies. All 1,500+ Veeva customers are life sciences organizations. The entire Veeva Quality Suite including QMS, QualityDocs, Training, LIMS, Batch Release, Validation Management, Station Manager, and Product Surveillance is designed specifically for pharma quality and compliance requirements.
Core Capabilities
FDA & GxP Compliance
International Standards
Security Certifications
Data Integrity & Validation
Veeva Vault Validation Management is delivered exclusively as cloud-based SaaS on the Veeva Vault Platform. Multi-tenant architecture with no on-premise deployment option. Access is through a mobile-responsive web interface via standard web browsers. No native mobile application is documented.
Integration capabilities provided through Veeva Connections Hub offering RESTful API connectivity for ERP systems (SAP, Oracle), MES, LIMS, document management, and third-party enterprise applications. Platform supports integration with other Veeva Vault applications including RIM (Regulatory Information Management), Clinical (eTMF, CTMS, EDC), Safety (Pharmacovigilance), and CRM (Commercial).
Deployment model is cloud-only SaaS with Veeva managing all infrastructure, security, upgrades, and releases. Built-in validation documentation provided with each release to reduce customer validation burden. System includes configurable workflows, electronic signatures, comprehensive audit trails, and real-time analytics across quality processes.
Geographic presence includes: North America, Europe (Germany, Spain, France, Italy specific sites), China, Japan, Asia Pacific, Korea, and Latin America (Portuguese/Spanish language support).
Subscription-based SaaS pricing model with per-user licensing. Starting price is reported as $25,000/year minimum for base subscriptions. Per-user costs range from $50-200/user/month depending on edition, module selection, and volume. No public fixed pricing available - customized quotes based on specific customer requirements, number of users, modules selected, and global deployment scope.
Subscription model includes: software licenses, automatic platform upgrades and releases, built-in validation documentation with each release, cloud infrastructure and hosting, security and compliance updates, and standard technical support.
Industries served beyond pharmaceuticals: MedTech (medical devices), Consumer Packaged Goods, Food & Beverage, and Chemical industries, though primary focus remains life sciences (pharma/biotech/medtech).
Implementation timeline ranges from accelerated deployments under tight deadlines to comprehensive 3-year global rollouts depending on organizational size, complexity, and scope. Case study: a global biopharmaceutical company completed a multi-year (3-year) implementation across thousands of users in over a dozen offices globally, replacing two prior systems using a three-phase approach.
8-Step Implementation Process: (1) Process Documentation & Analysis - document existing workflows and identify optimization opportunities, (2) Organizational Change Strategy - stakeholder buy-in, education, and infrastructure planning, (3-8) Configuration, validation, testing, training, deployment, and continuous improvement phases.
Implementation approach addresses: on-site requirements, previous system migration and data conversion, business process optimization, digital data volume and complexity management, user experience design, and scalability for global operations.
Implementation costs range from $10,000 to $50,000 for standard deployments. Customization services available with costs from $5,000 to $20,000 for SMB implementations, higher for enterprise-scale global deployments.
Built-in validation documentation provided with each Veeva release reduces customer validation burden. Cloud-based SaaS model eliminates infrastructure setup and hardware procurement. Professional services available from Veeva and certified implementation partners. Migration support includes data import capabilities through API connectivity.
Case study results: SK Life Science achieved "significant cost and time-savings" in test execution with Vault Validation Management, better data integrity, and improved audit readiness. Jazz Pharmaceuticals achieved "single source of truth; there is only one version" for all quality documents with enterprise-wide Vault QualityDocs deployment.
PharmaSpotter assessment from published vendor and third-party sources. No user reviews are on file for this product.
Strengths
SK Life Science reported "significant cost and time-savings" in test execution using Vault Validation Management, with better data integrity and improved audit readiness. Jazz Pharmaceuticals achieved "single source of truth; there is only one version" for quality documents with enterprise-wide deployment, eliminating version control issues. The Veeva Quality Suite serves 600+ quality customers; 19 of the top 20 pharmaceutical companies use Vault QualityDocs (replacing 13 legacy QMS systems), and a majority of the top 20 pharmaceutical companies use Veeva products overall. Veeva reported $699.2M in Q3 revenue as a public company, with continuing R&D investment and integration with the broader Veeva ecosystem.
Limitations & Open Questions
Users report ease-of-administration challenges. A case study for one global biopharmaceutical company recorded a multi-year (3-year) implementation timeline addressing previous-system migration complexity, business-process changes, digital data volume and complexity, and scalability requirements for thousands of users across dozens of global offices. Implementation complexity may be higher for large-scale global deployments replacing multiple legacy systems. Specific user complaints are undisclosed.
Help the community
Share your experience with Veeva Vault Validation Management anonymously. Your insights help pharmaceutical professionals make better software decisions.
Contribute Anonymous FeedbackPublicly disclosed pharmaceutical and biotech organizations
Jump to section